摘要
目的:对某三甲医院抗肿瘤药物用药的现状和趋势做出评价。方法:对该院2000～2004年使用抗肿瘤药物进行回顾性分析。结果:抗肿瘤药销售金额逐年上升;抗肿瘤辅助治疗药格拉司琼连续5年销售金额名列第一;5年中抗雌激素类抗肿瘤药他莫昔芬用药频度排名稳居榜首,其他类抗肿瘤药顺铂位居第二;国产药物销售金额始终最大;医保类药物在该院具有较高使用率。结论:该三甲医院抗肿瘤药物结构基本合理;坚持研发和使用国产药物,不断降低药品费用。
Objective： To evaluate present conditions and trend of anticancer drugs used in a 3A grade hospital. Method： Anticancer drugs used during the period 2000 - 2004 in that hospital was analysed retrospectively. Result： The sale sum of money of anticancer drugs increased year by year, in which that of Granisetron of supplementary drugs ranked in the first place for 5 years running. According to the order of DDDs, Tarnoxifen of anti-female hormone stably ranked top during 5 years, and Cisplatin ranked in the second place. The sale sum of money of domestic drugs was always the highest in the 5 years. There were high proportions of medicine-insurance drugs used in the hospital. Conclusion： There was a stable and rational structure of anticancer drugs in the 3A grade hospital. Keeping using domestic drugs so as to reduce the drug costs gradually.
出处
《中国药师》
CAS
2006年第2期159-162,共4页
China Pharmacist
关键词
抗肿瘤药
用药分析
趋势
Anticancer drugs
Analysis of drug use
Trend research
